No. | Author | Midazolam group | Control group | Jadad scores | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Number | Age (years) | Male (n) | Body mass (kg) | Surgery duration (min) | Methods | Number | Age (years) | Male (n) | Body mass (kg) | Surgery duration (min) | Methods | |||
1 | Sajedi 2014 | 25 | 26.9 ± 5.4 | 19 | 71.9 ± 4.5 | 49.2 ± 4.3 | 75 μg/kg intraarticular injection of midazolam and 10 ml intravenous injection of isotonic saline | 25 | 27.5 ± 5.1 | 22 | 70.7 ± 4.5 | 49.2 ± 4.6 | Intraarticular and intravenous injection of isotonic saline | 5 |
2 | Nanjegowda 2011 | 25 | 32.48 ± 11.13 | 9 | 63.36 ± 11.79 | – | 0.5% hyperbaric bupivacaine with preservative-free midazolam 2 mg intrathecally | 25 | 35.24 ± 10.91 | 10 | 63.36 ± 11.79 | – | 0.5% hyperbaric bupivacaine with saline intrathecally | 3 |
3 | He 2010 | 15 | 23–34 | – | 46.7–62.5 | – | 75 μg/kg intraarticular injection of midazolam | 15 | 23–34 | – | 46.7–62.5 | – | Intraarticular injection of saline | 3 |
4 | Cagla 2009 | 20 | 18–57 | 9 | 50–110 | – | Ketamine 0.15 mg/kg and midazolam 0.01 mg/kg intravenously | 20 | 16–65 | 11 | 55–95 | – | Intravenous ketamine 0.15 mg/kg | 4 |
5 | LI 2008 | 35 | 18–65 | – | – | – | Intraarticular 2% lidocaine and 2 mg midazolam | 35 | 18–65 | – | – | – | Intraarticular 2% lidocaine | 3 |
6 | Batra 2008 | 20 | 41 ± 4 | 14 | 69 ± 4 | – | Intraarticular midazolam 75 μg/kg | 20 | 40 ± 4.6 | 13 | 75 ± 3 | – | Intraarticular saline | 4 |